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Pleiotropic effects 
between cardiovascular disease risk 
factors and measures of cognitive 
and physical function in long‑lived 
adults
Julia J. Yudkovicz1, Ryan L. Minster2, Emma Barinas‑Mitchell1, Kaare Christensen3, 
Mary Feitosa4, Megan S. Barker5, Anne B. Newman1 & Allison L. Kuipers1*
Cardiovacular disease (CVD) is the leading cause of death among older adults and is often 
accompanied by functional decline. It is unclear what is driving this co‑occurrence, but it may be 
behavioral, environmental and/or genetic. We used a family‑based study to estimate the phenotypic 
and shared genetic correlation between CVD risk factors and physical and cognitive functional 
measures. Participants (n = 1,881) were from the Long Life Family Study, which enrolled families based 
on their exceptional longevity (sample mean age = 69.4 years, 44% female). Cardiovascular disease 
risk factors included carotid vessel measures [intima‑media thickness and inter‑adventitial diameter], 
obesity [body mass index (BMI) and waist circumference], and hypertension [systolic and diastolic 
blood pressures]. Function was measured in the physical [gait speed, grip strength, chair stand] and 
cognitive [digital symbol substitution test, retained and working memory, semantic fluency, and trail 
making tests] domains. We used SOLAR to estimate the genetic, environmental, and phenotypic 
correlation between each pair adjusting for age,  age2, sex, field center, smoking, height, and weight. 
There were significant phenotypic correlations (range |0.05–0.22|) between CVD risk factors and 
physical and cognitive function (all P < 0.05). Most significant genetic correlations (range |0.21–0.62|) 
were between CVD risk factorsand cognitive function, although BMI and waist circumference had 
significant genetic correlation with gait speed and chair stand time (range |0.29–0.53|; all P < 0.05). 
These results suggest that CVD risk factors may share a common genetic‑and thus, biologic‑basis 
with both cognitive and physical function. This is particularly informative for research into the genetic 
determinants of chronic disease.
Although cardiovascular disease (CVD) burden has recently been somewhat reduced through improved preven-
tion and treatment, it remains highly prevalent and the leading cause of death within the United States among 
men and women who are 65 years or  older1–4. Due to an aging population, the prevalence of dementia, frailty, 
and CVD will likely continue to increase. It is therefore important to investigate whether a biological link exists 
between these aging-related conditions.
Prior research has shown that a presence of CVD is associated with the level of cognitive and physical 
 functioning5–9. For instance, various cross-sectional studies have indicated that carotid intima-media thick-
ness (IMT) is negatively associated with working memory, psychomotor speed, delayed recall and executive 
 functioning5,6. There is also evidence that having a cardiovascular condition may put an individual at risk for 
future functional decline. For example in longitudinal studies, both a larger IMT and mid-life hypertension are 
associated with declines in executive functioning, retained memory, and category fluency, as well as a higher 
incidence of dementia, as indicated by several longitudinal  studies10–16.
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Most of the studied confounders or mediators of the relationship between CVD and function are biologic 
and/or behavioral, such as age, sex, excess weight, smoking, depression, education level and inactivity. However, 
each of these conditions is heritable in families, with specific estimates ranging from 0.21 for  IMT17 to 0.68 for 
inter-adventitial diameter (IAD)18, and estimates of heritability of BMI are 0.4–0.919–23. This suggests that there 
could be genetic correlations that exist between these aging-related disorders, which are often not considered 
in studies of co- or multi-morbidity in older adults. Investigating the shared etiology between cognitive and 
physical function and CVD may help to elucidate the pathophysiology of these conditions or provide potential 
targets for preventative strategies for co-morbidities in older adults.
Therefore, the purpose of this study was to determine the extent to which CVD risk factors, including meas-
ures of subclinical carotid vessel disease, obesity, and hypertension, are not only phenotypically correlated, 
but also genetically correlated with cognitive and physical function in adults from families with exceptional 
longevity from the Long Life Family Study (LLFS). We hypothesized that CVD risk factors will demonstrate an 
inverse genetic correlation with measures of cognitive and physical function, adjusting for demographic and 
environmental covariates.
Methods
Long life family study (LLFS) cohort. The LLFS cohort is comprised of multigenerational families 
selected for exceptional longevity. The study recruited participants from three sites across the United States 
(Pittsburgh, PA; Boston, MA; New York, NY) and Denmark, beginning in 2005. Families were recruited for 
this study based on first identifying long-lived individuals (probands) and their similarly long-lived siblings 
from public records (where “long-lived” was defined as aged 80 + years in the US and 90 + years in Denmark). 
Families were then assessed as to whether or not they demonstrated exceptional survival based on the Family 
Longevity Selection Score (FLoSS), which is a summary measure of the survival experience for probands and 
their siblings relative to what would be expected based on birth cohort-specific life tables and the availability of 
living subjects for the  study24. We also enrolled any interested siblings of the probands, as well as, all interested 
spouses and offspring.
All LLFS data were collected via in-home examination. Some measures of interest, such as the carotid ultra-
sound, were only collected at the second visit conducted between 2014–2017 (N = 2588; Fig. 1). Therefore, this 
analysis includes the 1,881 participants from visit 2 who had no missing data from any of the CVD risk factors 
or functional measures (N missing = 582 functional, 71 ultrasound, 54 covariates). The remaining participants 
included 138 in the proband generation (age range 56–106 years) and 1,743 in the offspring generation (age 
range 42–93 years). Detailed characteristics of the cohort have been described  elsewhere25. All study forms were 
approved and methods were performed in accordance with the relevant guidelines and regulations of the Insti-
tutional Review Boards at Boston University, Columbia University, and the University of Pittsburgh, and by the 
Research Ethics Committee at the University of Southern Denmark. Written informed consent to participate in 
the LLFS and to publish any related research findings was obtained from each LLFS participant.
Cardiovascular disease risk factors data collection. Carotid measures, including mean intima-media 
thickness (IMT) and inter-adventitial diameter (IAD), were obtained via B-mode ultrasound of the right and 
left common carotid arteries, as previously  described18. Briefly, a GE LOGIQ 3 BT12 Ultrasound System was 
used to conduct the imaging by centrally certified and trained researchers. A re-scan protocol (N = 10) was 
conducted per technician to ensure reproducibility and accuracy. Systolic and diastolic blood pressure (SBP and 
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Figure 1.  Flow-chart of Analytic Dataset from the Long Life Family Study. Depiction of the Long Life Family 
Study design, sample sizes, and exclusion criteria for the current study.
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DBP, respectively) were obtained sitting with an automated blood pressure machine and averaged over three 
measurements (BP-tru BPM 300, VMS MedTech, Coquitlam, Canada). For BMI, height was measured using a 
Handi-stat set (Perspective Enterprises, Portage, MI) to the nearest 0.1 cm and weight was determined using an 
electronic scale (SECA 841, Hanover, MD). BMI was calculated as weight(kg)/height(m2). Waist circumference 
(cm) was measured at the umbilicus while the participant stood erect using a soft tape.
Functional measure data collection. Cognitive function tests included the digit symbol substitution 
test (DSST), the number span test, the category (animal) fluency test, logical memory tests, and trail making 
tests. The DSST is used to measure a range of general cognitive operations including executive functions such as 
planning and strategizing, psychomotor speed, attention, and visuoperceptual functions such as manual dexter-
ity 26. The number span test estimates verbal working memory (i.e., short-term memory) which is often used 
in everyday tasks such as remembering a telephone number or understanding long  sentences27. The animal 
fluency test provides a measure of semantic fluency, by asking participants to say aloud all the animals they can 
within 60 s. Two logical memory tests (IA and IIA) were administered to measure retained memory by asking 
the participant to immediately recall a story verbatim (immediate recall) and then recall the same story after 20 
to 30 min (delayed recall)28, the percent which delayed memory score matches immediate score comprises the 
retained memory variable. The trail making tests (part A and part B) were used to measure psychomotor speed 
and visual scanning ability (Trails A), and executive functioning, specifically set-switching (Trails B)29–33.
Physical function measurements included grip strength, gait speed, and chair stand time. Grip strength was 
calculated using an isometric dynamometer (Jamar Hydraulic Hand Dynamometer, Lafayette, IN) over an average 
of two measurements and was rounded to the nearest 2 kg. Gait speed is reported in m/s and is the time required 
to walk 15 m in a straight-line, on a level indoor  surface34. Chair stand time (s) is how long it takes an individual 
to stand up from a straight-back chair without any assistance (i.e., not using their arms).
Additionally, information on each participant’s current smoking status was collected via interviewer-admin-
istered questionnaire.
Statistical analysis. The Sequential Oligogenic Linkage Analysis Routines (SOLAR) program accounts for 
family structure (i.e., relatedness) using maximum-likelihood based methods to estimate the residual genetic 
heritability  (h2r) of outcome measures, as well as, the variance attributable to fixed covariate  effects35. SOLAR 
first estimates the variance in a trait due to the included covariates (e.g., what is the proportion of the variation in 
the trait that can be attributed to the covariates?). Then it takes the residual unexplained variance in the trait and 
estimates the proportion of that attributed to inherited genetic variation (residual genetic heritability;  h2) based 
on the input family structure. SOLAR can also estimate the correlation due to shared genetic (i.e., pleiotropy; ρG) 
or shared environmental (ρE) determinants for pairs of  outcomes35,36. Phenotypic correlation (ρ) between trait 
pairs can then be estimated based on the residual heritability and the genetic and environmental correlations. 
In addition to accounting for family structure, we adjusted all models of carotid measures and blood pressure 
for age,  age2, sex, field centers, height, weight, and smoking, as they were significant predictors of the outcomes 
of interest and not an over-adjustment when considering the likely pleiotropic effects. To avoid multicollinear-
ity, models for obesity (BMI and waist circumference) did not include adjustment for weight (BMI also did 
not include height adjustment). Where needed, outcome variables were transformed to approximate normality 
before analysis in SOLAR.
Ethics approval. All study forms were approved and methods were performed in accordance with the rel-
evant guidelines and regulations of the Institutional Review Boards at Boston University, Columbia University, 
and the University of Pittsburgh, and by the Research Ethics Committee at the University of Southern Denmark
Informed consent. Written informed consent to participate in the LLFS and to publish any rela3ted 
research findings was obtained from each LLFS participant.
Results
The mean ages in both the proband (N = 138) and offspring (N = 1,743) generations were 89.43 ± 7.3 years and 
67.83 years±7.6 , respectively, with an overall average age of 69.4 ±9.5 (Table 1). Within the proband and offspring 
generations, 41% and 46% of the participants were female, respectively (Table 1). The proband generation has a 
notably larger IMT (1.01 ± 0.16 cm), IAD (8.29 ± 0.76 cm) and SBP (140.91 ± 20.94 mmHg) than the offspring 
generation who yielded an average IMT, IAD and SBP of 0.83 cm, 7.69 cm, and 133.39 mmHg, respectively. After 
adjustment, all studied outcome measures were significantly heritable (range: 0.13 for SBP to 0.62 for IAD; all 
p ≤ 0.01; Table 2). Model covariates explained between 4.77% (BMI) and 71% (grip strength) of the variance in 
outcome measures.
Phenotypic correlations between CVD risk factors and functional measures are shown in Table 3. BMI had 
significant phenotypic correlations with both the cognitive and physical functional measures except for retained 
memory and time required to complete Trails A. Waist circumference was phenotypically correlated with the 
same functional measures as BMI (Supplemental Table S1). Systolic and diastolic blood pressures had signifi-
cant correlation with grip strength (ρ = 0.06 for both). IAD was inversely correlated with DSST and gait speed 
(ρ = − 0.05 for both) but positively correlated with chair stand time (ρ = 0.05). However, there was no phenotypic 
correlation between IMT and any functional measure.
Genetic correlations between CVD risk factors and functional measures are shown in Table 4). There were 
significant (P < 0.05) genetic correlations between DSST and SBP (ρG = − 0.37), DBP (ρG = − 0.61), and BMI 
(ρG = − 0.21). Retained memory was genetically correlated with SBP (ρG = − 0.45) and BMI (ρG = − 0.34); whereas, 
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working memory was genetically correlated with IMT (ρG = − 0.26). Animal fluency was genetically correlated 
with systolic (ρG = − 0.40) and diastolic (ρG = − 0.45) blood pressures. The time required to complete Trails A 
was genetically correlated to diastolic (ρG = 0.49) but not, systolic blood pressure. Both gait speed and chair 
stand time were genetically correlated with BMI (ρG = − 0.40 and ρG = 0.29, respectively). Genetic correlations 
for waist circumference (Supplemental Table S1) were largely similar to those for BMI. In all cases, significant 
genetic correlations were significantly different from both 0 and 1, suggesting a portion but not all of their genetic 
covariance was shared between the trait pairs.
Environmental correlations, i.e. the correlation due to the included covariates, between CVD risk factors and 
functional measures are shown in Supplemental Table S2. These results show that environmental factors in these 
models (age, sex, field center, smoking status, and body size) showed significant covariance between CVD risk 
factors and measures of both cognitive and physical functioning.
Discussion
The genetic correlation results from this study in long-lived families provide novel evidence of shared genetic 
variance between cognitive function and CVD risk factors , as well as, between measures of physical function and 
obesity (Fig. 2). The study is also consistent with existing literature that demonstrated a phenotypic correlation 
Table 1.  Characteristics of LLFS Participants. *Characteristics shown as mean (SD) or frequency, as 
appropriate.
Overall (N = 1,881) Probands (N = 138) Offspring (N = 1,743)
Age (years) 69.42 (9.46) 89.43 (7.31) 67.83 (7.62)
Female (%) 45% 41% 46%
Current Smoking (%) 4.2% 2.2% 4.4%
Height (cm) 167.17 (9.78) 159.35 (9.10) 167.79 (9.56)
Weight (kg) 76.63 (16.11) 67.72 (12.59) 77.34 (16.15)
Waist (cm) 96.16 (12.86) 95.18 (10.38) 96.24 (13.0)
BMI (kg/m2) 27.33 (4.81) 26.57 (3.84) 27.39 (4.88)
Carotid IMT (mm) 0.840 (0.15) 1.01 (0.16) 0.83 (0.14)
IAD (mm) 7.73 (0.86) 8.29 (0.76) 7.69 (0.86)
SBP (mmHg) 133.39 (17.85) 140.91 (20.94) 132.79 (17.45)
DBP (mmHg) 74.64 (10.37) 67.47 (10.00) 75.21 (10.18)
Table 2.  Residual Genetic Heritability Estimates. *Residual heritability estimates shown range from 0–1 and 
demonstrate the proportion of the variance in the measure that is attributed to genetic factors after adjustment 
for covariates. Whereas, the variance explained by covariates is the proportion of the variance in the measure 
that is explained by the included covariates. Covariates for each model include: age,  age2, sex, field centers, 
height, weight, and whether an individual currently smokes. # Weight and height not included as covariates in 
BMI model; weight not included as covariate in waist circumference model.
Residual Heritability Estimate* Residual Heritability P-value Variance explained by covariates*
CVD risk factors
Carotid mean IMT (mm) 0.478 2.83 ×  10–17 0.399
Carotid mean IAD (mm) 0.621 3.94 ×  10–22 0.410
SBP (mmHg) 0.133 0.010 0.111
DBP (mmHg) 0.142 0.004 0.252
BMI (kg/m2)# 0.500 6.99 ×  10–17 0.477
Waist circumference (cm)# 0.494 7.63 ×  10–18 0.133
Cognitive function
DSST 0.417 5.38 ×  10–15 0.490
Retained memory 0.285 4.63 ×  10–8 0.213
Working memory 0.518 2.25 ×  10–17 0.280
Animal fluency 0.397 4.77 ×  10–13 0.255
Time to complete trails A 0.220 6.8 ×  10–06 0.437
Time to complete trails B 0.319 1.0 ×  10–07 0.464
Physical function
Grip strength (kg) 0.454 5.93 ×  10–18 0.711
Gait speed (m/s) 0.164 0.002 0.542
Chair stand time (s) 0.264 1.1 ×  10–05 0.255
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between lower physical function and adverse CVD risk factors. The significant pleiotropic results suggest that 
CVD is not only a risk factor for cognitive and physical decline, but may also be partially driven by the same 
genes and have a shared pathology.
The relationship between BMI and physical function is known to differ by age, such that a greater BMI in 
early to middle adulthood is associated with an increased risk of chronic disease and  mortality37, but in geriatric 
populations, greater BMI is associated with reduced frailty and a lower risk of morbidity and  mortality38. Not 
only does obesity in early to middle adulthood appear to increase mortality risk, but it also prompts declines in 
physical function and may even lead to overt frailty and it subsequent  outcomes39,40. In our study, both gait speed 
and chair stand time were genetically and phenotypically correlated with obesity (e.g., BMI, waist circumference), 
but not cardiovascular measures (e.g., IAD, IMT, SBP, DBP). This relationship is consistent and expands upon 
previous phenotypic correlation studies of obesity and frailty.
In addition to its shared genetic variance with physical function, we also found that BMI shares genetic 
variance with some measures of cognitive function. All of the cognitive measures that were genetically cor-
related with BMI approximate frontal lobe function, an area of the brain that is responsible for actions such 
as executive functioning and is susceptible to the detrimental effects of  aging41,42. These novel findings should 
Table 3.  Adjusted phenotypic correlations between CVD risk factors and cognitive and physical function. 
Values shown are correlation estimates (P-values) between CVD risk factor and cognitive or physical function 
measure as estimated by SOLAR. BOLD indicates a statistically significant correlation (P < 0.05). Covariate 
adjustments : age,  age2, sex, field centers, height, weight, and whether an individual currently smokes. *BMI 
models do not include adjustment for height or weight.
Phenotypic correlation: ρ (P-value)
Carotid IMT Carotid IAD SBP DBP BMI*
Cognitive function
DSST − 0.042 (0.06) − 0.052 (0.02) − 0.030 (0.16) − 0.033 (0.19) − 0.102 (< 0.01)
Retained memory (Delayed/Immediate) − 0.003 (0.91) − 0.003 (0.89) − 0.044 (0.05) − 0.018 (0.43) − 0.003 (0.89)
Working memory − 0.013 (0.56) 0.024 (0.30) − 0.019 (0.38) − 0.026 (0.24) − 0.071 (< 0.01)
Animal fluency − 0.003 (0.88) 0.005 (0.82) − 0.023 (0.35) − 0.017 (0.44) − 0.067 (< 0.01)
Time to complete trails A − 0.009 (0.68) 0.010 (0.66) 0.026 (0.22) 0.034 (0.11) 0.030 (0.17)
Time to complete trails B 0.024 (0.29) 0.012 (0.61) 0.036 (0.10) 0.032 (0.14) 0.075 (< 0.01)
Physical function
Grip strength − 0.035 (0.12) − 0.034 (0.12) 0.059 (0.01) 0.063 (< 0.01) 0.045 (0.04)
Gait speed − 0.026 (0.22) − 0.048 (0.03) 0.008 (0.70) − 0.006 (0.79) − 0.225 (< 0.01)
Chair stand time 0.013 (0.56) 0.051 (0.02) − 0.025 (0.27) − 0.034 (0.13) 0.173 (< 0.01)
Table 4.  Adjusted genetic correlations (ρG) between CVD risk factors and cognitive and physical function. 
Values shown are estimates of the correlation between CVD risk factor and cognitive or physical function 
measure that is due to genetic factors (e.g., genetic correlation (ρG). P-values are shown both for the test 
for a significant difference from zero (0) (i.e., some shared genetic variance;  P0) and the test of a significant 
difference from unity (1) (i.e., completely shared genetic variance;  P1). To facilitate quick interpretation, all 
instances of significant genetic correlation are shown in BOLD. Covariate adjustments: age,  age2, sex, field 
centers, height, weight, and whether an individual currently smokes. *BMI models do not include adjustment 
for height or weight.
Carotid IMT Carotid IAD SBP DBP BMI*
ρG P0 |  P1 ρG P0 |  P1 ρG P0 |  P1 ρG P0 |  P1 ρG P0 | P1
Cognitive function
DSST − 0.015 0.88 | 5.6 ×  10–15 − 0.026 0.79 | 5.9 ×  10–15 − 0.374 0.04 | 0.02 − 0.610 3.0 × 10–4 | 0.049 − 0.206 0.049 | 2.1 × 10–12
Retained memory (Delayed/
Immediate) 0.110 0.40 | 2.0 ×  10
–7 0.065 0.12 | 3.0 ×  10–7 − 0.454 0.04 | 0.04 − 0.355 0.09 | 0.01 − 0.340 0.01 | 1.7 × 10–5
Working memory − 0.264 0.01 | 2.2 × 10–10 0.064 0.49 | 2.3 ×  10–17 − 0.236 0.19 | 0.02 − 0.121 0.48 | 0.005 − 0.165 0.10 | 3.3 ×  10–15
Animal fluency 0.054 0.62 | 1.8 ×  10–10 0.089 0.39 | 9.1 ×  10–12 − 0.396 0.04 | 0.03 − 0.445 0.02 | 0.02 − 0.142 0.20 | 7.4 ×  10–12
Time to complete trails A − 0.071 0.60 | 9.2 ×  10–6 − 0.034 0.79 | 7.0 ×  10–6 0.168 0.48 | 0.01 0.485 0.03 | 0.04 0.140 0.30 | 9.4 ×  10–6
Time to complete trails B 0.083 0.51 | 2.0 ×  10–7 − 0.071 0.55 | 2.0 ×  10–7 0.180 0.43 | 0.01 0.264 0.21 | 0.006 0.221 0.08 | 6.0 ×  10–7
Physical function
Grip strength − 0.089 0.38 | 1.2 ×  10–14 − 0.008 0.93 | 2.6 ×  10–16 − 0.238 0.21 | 0.03 − 0.277 0.11 | 0.01 0.002 0.99 | 1.2 ×  10–17
Gait speed 0.010 0.95 | 0.002 0.135 0.39 | 0.003 0.027 0.93 | 0.02 − 0.217 0.42 | 0.008 − 0.404 0.01 | 0.003
Chair stand time − 0.064 0.64 | 1.0 ×  10–5 − 0.010 0.94 | 1.3 ×  10–5 0.257 0.32 | 0.02 0.198 0.39 | 0.007 0.294 0.03 | 6.2 × 10–6
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motivate researchers to investigate the shared pathophysiology between CVD risk factors, obesity in particular, 
and aging-related functional decline.
Unlike BMI, measures of subclinical carotid vessel disease were not genetically correlated with measures of 
physical function, although there were some significant phenotypic correlations. These phenotypic results are 
consistent with previous findings in healthy aging cohorts. In the Health ABC study, researchers found that both 
peripheral artery disease and subclinical atherosclerosis were cross-sectionally associated with walking speed 
after adjustment for potential  confounders43. They also demonstrated that while frailty may precede 10-year heart 
failure  incidence44, arterial fibrillation may actually precede and contribute to longitudinal physical  decline45. 
This inconsistency in the temporal relationship between carotid vessel disease and physical function highlight a 
need for further research and, since our study did not find evidence of a shared genetic pathway between carotid 
vessel disease and physical function, the potential shared environmental determinants of these disorders should 
be of particular focus.
In contrast, measures of subclinical carotid vessel disease showed significant genetic correlation with cogni-
tive measures, specifically those that approximate working memory, executive functioning and semantic fluency 
performance. Our results align with previous studies which demonstrate a longitudinal association between CVD 
and cognitive  decline10–16. However, unlike physical function, which showed both strong phenotypic and genetic 
correlations with CVD risk factors , cognitive function had significant genetic, but not phenotypic, correlation 
with CVD risk factors. One potential explanation could be that phenotypic correlation is an aggregate of both 
the genetic and environmental correlation values. For example, take IMT and working memory: their genetic 
correlation is negative, but the environmental correlation is positive (Supplemental Table S2), thus resulting in 
an insignificant phenotypic correlation. This incongruence between the direction of genetic and environment 
effects may be partially driven by the wide age-range of our participants. When we exclude age as a covariate 
from the model, the environmental correlation effect becomes negative, thus mirroring the direction of the 
genetic correlation. While there is no procedure to test for interactions or modification in analyses of genetic 
correlation using a family study design, future research should be conducted in narrow age ranges in order to 
identify age-specific directionality of the genetic and phenotypic relationship between cognitive function and 
carotid vessel disease. It is possible that there is a non-linear relationship of carotid vessel disease and cognitive 
function, similar to that of BMI and physical function declines discussed above.
One important limitation is that due to the cross-sectional nature of this study, we cannot assess temporality, 
meaning we can’t know for sure whether declines in function preceded, succeeded or occurred concurrently with 
the incidence of CVD. Also, since the main objective of the LLFS is to discover factors associated with exceptional 
longevity, the older-lived subjects in this study may have been healthier across their lifespan compared to the 
general  population25,46,47. Thus, it is possible that they harbor unique genetic interactions or pleiotropic effects 
that may not apply to the general population. However, the estimation of genetic correlation requires a family-
study design. As such, given the extensive outcome measurements and unique design, the LLFS is ideally suited 
to perform these analyses. Additionally, because this is a family-based study, family members likely experience 
shared lifestyles or environments for at least a portion of their lives, and therefore, we may be at risk of overes-
timating the genetic correlation and heritability of certain  traits48,49. Since our primary goal was to estimate the 
genetic correlation between CVD risk factors and age-related functional measures, our focus was on including 
adjustment for biologic covariates outside of the biologic pathways of interest. However, it is possible that there 
may be some environmental covariates such as education and  depression5,10,12,15 that we did not include in this 
study, which could be important particularly for phenotypic correlation results. Also, it is known that there is 
a tight relationship between obesity and type 2 diabetes, such that obesity is considered a precursor for type 2 
 diabetes50. Therefore, we did not consider type 2 diabetes or other CVDs (e.g., dyslipidemia, heart failure, stroke) 
as covariates because they are in the causal pathway between CVD risk factors and functional decline, it would 
be an over-adjustment in estimating the proportion of their shared genetic variance. However, we believe that 
Figure 2.  Summary Diagram of the Current Study’s Purpose and Findings. Infographic of the study purpose 
(dashed green line, top portion of figure) and findings (bottom portion of figure), including highlighting trait 
pairs with significant phenotypic (blue lines) or genetic (green lines) correlations.
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these other comorbidities and CVDs are important to consider when evaluating the relationship between CVD 
risk factors and functional decline.
The overall findings of our study suggest that CVD risk factors may share genetic determinants with both 
cognitive and physical function, thus suggesting there may be common physiological mechanisms linking these 
age-related disorders. These results help to improve our understanding of the underlying biologic links between 
aging-related conditions and may prompt innovations in geriatric care, particularly in those afflicted with car-
diovascular disease. The next step for this research should attempt to replicate and extend these findings in other 
studies that are reflective of the general adult population, as well as, attempting to identify genes and/or pathways 
responsible for the pleiotropy between these measures in the LLFS.
Data availability
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